ARCHIVES

FDA Issues Final Rules On Patient Access To Investigational Drugs

This article is from The Cancer Letter archive.

Vol. 35 No. 33 | September 11, 2009

Download PDF Visit The Full Archive

Related Articles

NCI May Ask Grantees To Assume Additional Services, Broder Says

November 11, 1994

NKTR-102 Shows 29 Percent Response in Phase II Study

September 30, 2011

Shift Towards More Treatable AIDS Lymphomas Identified

July 25, 2003

Aging Committee Hears Prospects For Immunotherapy

July 27, 1979

In Brief: NCI Award 14 Contracts to Operate The Cancer Information Service

August 13, 1999

NCI’s use of Cancer Dialogue for biospecimen network blueprint raises legal, procedural questions.

December 12, 2003